P. W. Jones
- Analysis of the cues used by patients when making assessments of their asthma severityBy E. A. Barley and P. W. Jones
- Predictors of success and failure in pulmonary rehabilitationBy R. Garrod, J. Marshall, E. Barley and P. W. JonesR. GarrodJ. MarshallE. Barley
- Outcomes and markers in the assessment of chronic obstructive pulmonary diseaseBy P. W. Jones and A. G. N. Agusti
- Outcomes for COPD pharmacological trials: from lung function to biomarkersBy M. Cazzola, W. MacNee, F. J. Martinez, K. F. Rabe, L. G. Franciosi, P. J. Barnes, V. Brusasco, P. S. Burge, P. M. A. Calverley, B. R. Celli, P. W. Jones, D. A. Mahler, B. Make, M. Miravitlles, C. P. Page, P. Palange, D. Parr, M. Pistolesi, S. I. Rennard, M. P. Rutten-van Mölken, R. Stockley, S. D. Sullivan, J. A. Wedzicha and E. F. WoutersM. CazzolaW. MacNeeF. J. MartinezK. F. RabeL. G. FranciosiP. J. BarnesV. BrusascoP. S. BurgeP. M. A. CalverleyB. R. CelliP. W. JonesD. A. MahlerB. MakeM. MiravitllesC. P. PageP. PalangeD. ParrM. PistolesiS. I. RennardM. P. Rutten-van MölkenR. StockleyS. D. SullivanJ. A. Wedzicha
- Statistical analysis of exacerbation rates in COPD: TRISTAN and ISOLDE revisitedBy O. N. Keene, P. M. A. Calverley, P. W. Jones, J. Vestbo and J. A. AndersonO. N. KeeneP. M. A. CalverleyP. W. JonesJ. Vestbo
- Statistical analysis of COPD exacerbationsBy O. N. Keene, P. M. A. Calverley, P. W. Jones, J. Vestbo and J. A. AndersonO. N. KeeneP. M. A. CalverleyP. W. JonesJ. Vestbo
- From the authorsBy O. N. Keene, P. M. A. Calverley, P. W. Jones, J. Vestbo and J. A. AndersonO. N. KeeneP. M. A. CalverleyP. W. JonesJ. Vestbo
- Lung function decline in COPD trialsBy O. N. Keene, B. Celli, J. A. Anderson, G. T. Ferguson, C. R. Jenkins, P. W. Jones, J. Vestbo, K. Knobil, J. C. Yates and P. M. A. CalverleyO. N. KeeneB. CelliJ. A. AndersonG. T. FergusonC. R. JenkinsP. W. JonesJ. VestboK. KnobilJ. C. Yates
- Methods for therapeutic trials in COPD: lessons from the TORCH trialBy O. N. Keene, J. Vestbo, J. A. Anderson, P. M. A. Calverley, B. Celli, G. T. Ferguson, C. Jenkins and P. W. JonesO. N. KeeneJ. VestboJ. A. AndersonP. M. A. CalverleyB. CelliG. T. FergusonC. Jenkins
- Pneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: TORCH study resultsBy C. Crim, P. M. A. Calverley, J. A. Anderson, B. Celli, G. T. Ferguson, C. Jenkins, P. W. Jones, L. R. Willits, J. C. Yates and J. VestboC. CrimP. M. A. CalverleyJ. A. AndersonB. CelliG. T. FergusonC. JenkinsP. W. JonesL. R. WillitsJ. C. Yates
- Development and first validation of the COPD Assessment TestBy P. W. Jones, G. Harding, P. Berry, I. Wiklund, W-H. Chen and N. Kline LeidyP. W. JonesG. HardingP. BerryI. WiklundW-H. Chen
- Is treatment with ICS and LABA cost-effective for COPD? Multinational economic analysis of the TORCH studyBy A. H. Briggs, H. A. Glick, G. Lozano-Ortega, M. Spencer, P. M. A. Calverley, P. W. Jones and J. VestboA. H. BriggsH. A. GlickG. Lozano-OrtegaM. SpencerP. M. A. CalverleyP. W. Jones
- Cognitive function in COPDBy J. W. Dodd, S. V. Getov and P. W. JonesJ. W. DoddS. V. Getov
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.